iSpecimen (ISPC) Profit After Tax Growth (3y) (2023 - 2026)
iSpecimen (ISPC) Profit After Tax Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 8.53% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -1.85% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 14.70% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -4.58% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 13.70% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 6.28% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.28% |
| 10 | iSpecimen | 658,857.59 | -2.16 Mn | 71,599.00 | 2.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.19% |
| Dec 31, 2025 | -32.30% |
| Sep 30, 2025 | 3.51% |
| Jun 30, 2025 | 26.21% |
| Mar 31, 2025 | 11.39% |
| Dec 31, 2024 | -43.40% |
| Sep 30, 2024 | 2.49% |
| Jun 30, 2024 | -14.77% |
| Mar 31, 2024 | 9.87% |
| Dec 31, 2023 | -24.46% |
| Sep 30, 2023 | -19.20% |
| Jun 30, 2023 | -171.49% |